Mrinalini Bilgi

828 citations
9 papers · 558 indexed · h-index 7
Topics
CAR-T cell therapy research (7 papers)Immunotherapy and Immune Responses (2 papers)Histiocytic Disorders and Treatments (2 papers)
Partner nations
United StatesMexico

In The Last Decade

Mrinalini Bilgi

9 papers receiving 552 citations

Peers

Mrinalini Bilgi
Comparison fields: 5 of 33
  • Oncology 393
  • Physiology 173
  • Pathology and Forensic Medicine 170
  • Immunology 117
  • Genetics 111
Replace Elizabeth M. Sagatys with:
Elizabeth M. Sagatys United States
Martina Pennisi Italy
Kathryn Lurain United States
Omeed Memar United States
Gloria Iacoboni Spain
Emanuela Passoni Italy
Riccardo Turrini Italy
Jose Sandoval‐Sus United States
Albert Quiery United States
Harshal Abhyankar United States
Mrinalini Bilgi relative to Elizabeth M. Sagatys United States Elizabeth M. Sagatys's profile →
Citations per field
00.5×3.1×
Elizabeth M. Sagatys · 1×
Citations per year

Countries citing papers authored by Mrinalini Bilgi

Since Specialization
Citations

This map shows the geographic impact of Mrinalini Bilgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mrinalini Bilgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mrinalini Bilgi more than expected).

Fields of papers citing papers by Mrinalini Bilgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mrinalini Bilgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mrinalini Bilgi. The network helps show where Mrinalini Bilgi may publish in the future.

Co-authorship network of co-authors of Mrinalini Bilgi

This figure shows the co-authorship network connecting the top 25 collaborators of Mrinalini Bilgi. A scholar is included among the top collaborators of Mrinalini Bilgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mrinalini Bilgi. Mrinalini Bilgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 51
2 8
3 21
4 2
5 1
6 23
7 279
8 86
9 87

About Mrinalini Bilgi

Mrinalini Bilgi is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine, having authored 9 papers that have together received 558 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (2 papers) and Histiocytic Disorders and Treatments (2 papers). The work is most often cited by research in Oncology (393 citations), Pathology and Forensic Medicine (170 citations) and Physiology (173 citations). Mrinalini Bilgi has collaborated with scholars based in United States and Mexico. Frequent co-authors include Olga Dakhova, Malcolm K. Brenner, Barbara Savoldo, Carlos A. Ramos, Gianpietro Dotti, Helen E. Heslop, Cliona M. Rooney, Bambi Grilley, Adrian P. Gee and Zhuyong Mei. Their work appears in journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026